Antidiabetic and antioxidant activities of ethanolic extract of Semecarpus anacardium (Linn.) bark

BMC Complementary and Alternative Medicine

Volumn 15, Issue 1, 2015, Pages

  Ali, Md Ashraf ^a,c   Wahed, Mir Imam Ibne ^b   Khatune, Naznin Ara ^b   Rahman, Bytul Mokaddesur ^b   Barman, Kumar Barman ^b   Islam, Md Rafiqul ^d  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b UNIVERSITY OF RAJSHAHI   (Bangladesh)

^c MAWLANA BHASHANI SCIENCE AND TECHNOLOGY UNIVERSITY   (Bangladesh)

^d JASHORE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Bangladesh)

Author keywords

Antidiabetic activity, Antioxidant activity; Blood glucose; Lipid profile; Liver enzyme; Semecarpus anacardium (SA)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FLAVONOID; GLUCOSE; GLYCOGEN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PHENOL DERIVATIVE; PHYTOSTEROL; PLANT GLYCOSIDE; PLANT MEDICINAL PRODUCT; SAPONIN; SEMECARPUS ANACARDIUM EXTRACT; TANNIN DERIVATIVE; TRIACYLGLYCEROL; TRITERPENOID; 2,2-DIPHENYL-1-PICRYLHYDRAZYL; ANTIDIABETIC AGENT; ANTIOXIDANT; BIPHENYL DERIVATIVE; GLUCOSE BLOOD LEVEL; INSULIN; PICRIC ACID; PLANT EXTRACT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BARK; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DPPH RADICAL SCAVENGING ASSAY; DRUG SCREENING; ERYTHROCYTE COUNT; GLUCOSE BLOOD LEVEL; GLYCOGEN ANALYSIS; GLYCOGEN LIVER LEVEL; HEART WEIGHT; IC50; KIDNEY MASS; LIVER WEIGHT; LUNG WEIGHT; MALE; NONHUMAN; PANCREAS; RAT; SEMECARPUS ANACARDIUM; SOLVENT EXTRACTION; SURVIVAL RATE; WEIGHT CHANGE; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; METABOLISM; PHYTOTHERAPY; PLANT STEM; SEMECARPUS; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BIPHENYL COMPOUNDS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FLAVONOIDS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PHENOLS; PHYTOTHERAPY; PICRATES; PLANT BARK; PLANT EXTRACTS; PLANT STEMS; RATS; RATS, WISTAR; SEMECARPUS;

EID: 84929402523     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-015-0662-z     Document Type: Article

References (44)

1. David MN, James M, Daniel ES. The epidemiology of cardiovascular disease in type 2 diabetes mellitus, how sweet it is or is it. Lancet. 1997;350 Suppl 1:S14-9.
2. American Diabetes Association. Adapted from the Report of the American Diabetes Association (ADA) Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetic Care. 2002;25 Suppl 1:S5-20.
3. Luzi L. Pancreas transplantation and diabetic complications. N Engl J Med. 1998;339:115-7.
4. Rajshahi Diabetes Association. 19th Annual General Meeting. 2005.
5. King H, Abubert RE, Herman WH. Global burden of diabetes 1995-2025, preyalence, numerical estimates and projection. Diabetes Care. 1998;21:1414-31.
6. Markuszewski L, Bodalska J, Kaminski G, Kuberska-Kedzierska M. Usefulness of measurement of glucose and glycosylated hemoglobin levels in patients with acute coronary syndrome as number predictors of stenotic coronary arteries shown in coronary arteriography. Pol Merkur Lekarski. 2006;20:270-3.
7. Brown WV. Lipoprotein disorders in diabetes mellitus. Med Clin North Am. 1994;87:143-61.
8. Stamler I, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12-yrs cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;15:434-44.
9. Howland RD, Mycek MJ. Lippincott's Illustrated Reviews, Pharmacology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 245.
10. Libby P, Plutzky J. Diabetic macrovascular disease the glucose paradox? Circulation. 2002;106:2760.
11. Bierman EL, Glomset JA. Disorders of lipid metabolism. In: Williams textbook of endocrinology. 8th ed. Philadelphia: Saunders; 1992.
12. Lyons TJ. Lipoprotein glycation and its metabolic complications. Diabetes. 1992;41 Suppl 2:67-73.
13. Biesbroeck RC, Albers JJ, Wahl PW, Weinberg CR, Basset ML, Bierman EL. Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics. Diabetes. 1982;31:126-31.
14. Barbaras R, Puchois P, Fruchart JC, Ailhaud G. Cholesterol efflux from cultured adipose cells is mediated by Lp AI particles but not LpAI: AII particles. Biochem Biophys Res Commun. 1987;142:63-9.
15. Oram JF. Can insulin promote atherogenesis by altering cellular cholesterol metabolism? J Lab Clin Med. 1995;126:229-30.
16. Augusti KT. Studies on the effect of a hypoglycaemic principles from Allium cepa Linn. Indian J Med Res. 1973;61(6):1066.
17. Grover JK, Yadav S, Vats V. Medicinal plants of India with antidiabetic potential. J Ethnopharmacol. 2002;81:81.
18. Nadikarni AK. Indian Materia Medica. 3rd ed. Bombay: Popular Book Depot, Ltd.; 1954.
19. Ramprasath VR, Shanthi P, Sachdanandam P. Immunomodulatory and anti-inflammatory effects of Semecarpus anacardium Linn. nut milk extract in experimental inflammatory conditions. Biol Pharm Bull. 2006;29(4):693-700.
20. Hembree JA, Chang CJ, McLaughlin JL, Peck G, Cassady JM. The anticancer activity of Semecarpus anacardium L. 9 KB active pentadecylcatechols. Lloydia. 1978;41(5):491-3.
21. Kirtikar KR, Basu BD. Indian Medicinal Plants, vol. I. 2000th ed. Delhi: Sri Satguru Publications; 2000. p. 667-8.
22. Selvam C, Jachak SM. A cyclooxygenase (COX) inhibitory biflavonoid from the seeds of Semecarpus anacardium. J Ethnopharmacol. 2004;95(2-3):209-12.
23. Gil RR, Lin LZ, Cordell GA, Kumar MR, Ramesh M, Reddy BM, et al. Anacardoside from the seeds of Semecarpus anacardium. Phytochemistry. 1995;39(2):405-7.
24. Kothai R, Arul B, Kumar KS, Christina AJ. Hypoglycemic and antihyperglycemic effects of Semecarpus anacardium linn in normal and alloxan-induced diabetic rats. J Herb Pharmacother. 2005;5(2):49-56.
25. Sharma A, Mathur R, Dixit VP. Hypocholesterolemic activity of nut shell extract of Semecarpus anacardium (Bhilawa) in cholesterol fed rabbits. Indian J Exp Biol. 1955;33(6):444-8.
26. Chitnis MP, Bhatia KG, Phatak MK, Kesava Rao KV. Anti-tumour activity of the extract of Semecarpus anacardium L. nuts in experimental tumor model. Indian J Exp Biol. 1980;18(1):6-8.
27. Verma N, Vinayak M. Semecarpus anacardium nut extract promotes the antioxidant defence system and inhibits anaerobic metabolism during development of lymphoma. Biosci Rep. 2009;29(3):151-64.
28. Premalatha B, Sachdanandam P. Potency of Semecarpus anacardium Linn. nut milk extract against aflatoxin B(1)-induced hepatocarcinogenesis: reflection on microsomal biotransformation enzymes. Pharmacol Res. 2000;42(2):161-6.
29. Phatak MK, Ambaye RY, Indap MA, Bhatia KG. Cytotoxicity of the acetylated oil of Semecarpus anacardium Linn. Indian J Physiol Pharmacol. 1983;27(2):166-70.
30. Sharma K, Shukla SD, Mehta P, Bhatnagar M. Fungistatic activity of Semecarpus anacardium Linn. of nut extract. Indian J Exp Biol. 2002;40(3):314-8.
31. Tripathi YB, Singh AV. Effect of Semecarpus anacardium nuts on lipid peroxidation. Indian J Exp Biol. 2001;39(8):798-801.
32. Tarnoky K, Nagy S. Spectrophotometric determination of glycogen with O-toludine. Clin Chim Acta. 1963;8:627-8.
33. Yen G-C, Chen H-Y. Antioxidant activity of various tea extracts in relation to their antimutagenicity. J Agric Food Chem. 1995;43:27-32.
34. Pollock JRA, Stevens R. Dictionary of Organic Compounds, vol. 5. 4th ed. London: Eyre and Spottishwoode Publishers; 1965.
35. Trease GE, Evans WC. Pharmacognosy. 12th ed. Baillier Tindall, East Bourne: ELBS Publications; 1996. p. 344-539.
36. Plummer DI. An Introduction to Practical Biochemistry. 2nd ed. New Delhi: Tata Magraw-Hill Publishing Co. Ltd; 1985. p. 136-43.
37. McDonald S, Prenzler PD, Autolovich M, Robards K. Phenolic content and antioxidant activity of olive oil extracts. Food Chem. 2001;73:73-84.
38. Kumaran K. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Anal. 2007;10(3):178-82.
39. Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 2004;92:1-21.
40. Lyra R, Oliveira M, Lins D, Cavalcanti N. Prevention of type 2 diabetes mellitus. Arq Bras Endocrinol Metabo. 2006;50:239-49.
41. Mythilypriya R, Shanthi P, Sachdanandam P. Oral acute and subacute toxicity studies with Kalpaamrutha, a modified indigenous prepraration on rats. J Health Science. 2007;53(4):351-8.
42. Ali MA, Sultana MC, Rahman BM, Khatune NA, Wahed MII. Antidiabetic activity of ethanolic extract of Semecarpus anacardium (linn.) Stem barks in normal and alloxan induced diabetic rats. Int J Pharm Sci Res. 2012;3(8):2680-5.
43. Choudhari CV, Deshmukh PB. Acute and subchronic toxicity study of Semecarpus anacardium on Hb % and RBC count of male albino rats. J Herbal Med and Toxicol. 2007;1:43-5.
44. Choi HY, Jhun EJ, Lim BO. Application of flow injectionchemilumineacence to the study of radical scavenging activity in plants. Phytother Res. 2000;14:250-3.